Simple scale-up of recombinant antibody production using an UCOE containing vector

Sabrina Boscolo; Francesca Mion; Marta Licciulli; Paolo Macor; Luca De Maso; Martina Brce; Michael N. Antoniou; Roberto Marzari; Claudio Santoro; Daniele Sblattero

doi:10.1016/j.nbt.2011.12.005

Simple scale-up of recombinant antibody production using an UCOE containing vector

Sabrina Boscolo
, Francesca Mion
, Marta Licciulli
, Paolo Macor
, Luca De Maso
, Martina Brce
, Michael N. Antoniou
, Roberto Marzari
, Claudio Santoro
, Daniele Sblattero

Department of Health Sciences

Research output: Contribution to journal › Article › peer-review

Abstract

Recombinant proteins, in particular antibodies, have become fundamental in biomedical research where they are used in numerous therapeutic and diagnostic applications. For this reason there is an increasing demand for quick and economical production systems for recombinant proteins in mammalian cells.

Original language	English
Pages (from-to)	477-484
Number of pages	8
Journal	New Biotechnology
Volume	29
Issue number	4
DOIs	https://doi.org/10.1016/j.nbt.2011.12.005
Publication status	Published - 15 May 2012

Access to Document

10.1016/j.nbt.2011.12.005

Cite this

@article{bfab828a0d0b4da3bc3ce04dd20896c8,

title = "Simple scale-up of recombinant antibody production using an UCOE containing vector",

abstract = "Recombinant proteins, in particular antibodies, have become fundamental in biomedical research where they are used in numerous therapeutic and diagnostic applications. For this reason there is an increasing demand for quick and economical production systems for recombinant proteins in mammalian cells.",

author = "Sabrina Boscolo and Francesca Mion and Marta Licciulli and Paolo Macor and \{De Maso\}, Luca and Martina Brce and Antoniou, \{Michael N.\} and Roberto Marzari and Claudio Santoro and Daniele Sblattero",

note = "Funding Information: This work was supported by grants provided by Fondazione Cariplo Bando Ricerca Biomedica 2009, Compagnia Sanpaolo, the Italian Association for Cancer Research (AIRC), by Fondazione Casali (Trieste) and by Regione Friuli-Venezia Giulia (AITT-2008 and LinfoNet-2008).",

year = "2012",

month = may,

day = "15",

doi = "10.1016/j.nbt.2011.12.005",

language = "English",

volume = "29",

pages = "477--484",

journal = "New Biotechnology",

issn = "1871-6784",

publisher = "Elsevier B.V.",

number = "4",

}

TY - JOUR

T1 - Simple scale-up of recombinant antibody production using an UCOE containing vector

AU - Boscolo, Sabrina

AU - Mion, Francesca

AU - Licciulli, Marta

AU - Macor, Paolo

AU - De Maso, Luca

AU - Brce, Martina

AU - Antoniou, Michael N.

AU - Marzari, Roberto

AU - Santoro, Claudio

AU - Sblattero, Daniele

N1 - Funding Information: This work was supported by grants provided by Fondazione Cariplo Bando Ricerca Biomedica 2009, Compagnia Sanpaolo, the Italian Association for Cancer Research (AIRC), by Fondazione Casali (Trieste) and by Regione Friuli-Venezia Giulia (AITT-2008 and LinfoNet-2008).

PY - 2012/5/15

Y1 - 2012/5/15

N2 - Recombinant proteins, in particular antibodies, have become fundamental in biomedical research where they are used in numerous therapeutic and diagnostic applications. For this reason there is an increasing demand for quick and economical production systems for recombinant proteins in mammalian cells.

AB - Recombinant proteins, in particular antibodies, have become fundamental in biomedical research where they are used in numerous therapeutic and diagnostic applications. For this reason there is an increasing demand for quick and economical production systems for recombinant proteins in mammalian cells.

UR - https://www.scopus.com/pages/publications/84860356388

U2 - 10.1016/j.nbt.2011.12.005

DO - 10.1016/j.nbt.2011.12.005

M3 - Article

SN - 1871-6784

VL - 29

SP - 477

EP - 484

JO - New Biotechnology

JF - New Biotechnology

IS - 4

ER -

Simple scale-up of recombinant antibody production using an UCOE containing vector

Abstract

Access to Document

Other files and links

Fingerprint

Cite this